Admission biomarkers and COVID-19 mortality: A retrospective study during Vietnam’s pandemic peak
References
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine. 2020;382(18):1708–20.
- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis : JTH. 2020;18(4):844–7.
- Zhou C, Bu G, Sun Y, Ren C, Qu M, Gao Y, et al. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay. Journal of medical virology. 2021;93(5):2857–66.
- He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Scientific reports. 2021;11(1):1830.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020;323(11):1061–9.
- Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–41.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497–506.
- Heber S, Pereyra D, Schrottmaier WC, Kammerer K, Santol J, Rumpf B, et al. A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation. Frontiers in cellular and infection microbiology. 2021;11:795026.
- Hardy M, Lecompte T, Douxfils J, Lessire S, Dogné JM, Chatelain B, et al. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thrombosis journal. 2020;18:17.
- Minh LHN, Khoi Quan N, Le TN, Khanh PNQ, Huy NT. COVID-19 Timeline of Vietnam: Important Milestones Through Four Waves of the Pandemic and Lesson Learned. Frontiers in public health. 2021;9:709067.
- Khue LN, Khoa NT, Duong VA, Hien DTH, Otsu S, Quang PK, et al. How Ho Chi Minh City adapted its care pathway to manage the first large-scale community transmission of COVID-19. Western Pac Surveill Response J. 2023;14(5 Spec Ed):1–4.
- Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied Linear Statistical Models. 5th ed. New York: McGraw-Hill Irwin; 2005.
- Polo TCF, Miot HA. Use of ROC curves in clinical and experimental studies. Jornal vascular brasileiro. 2020;19:e20200186.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395(10229):1054–62.
- Kim Y, Khose S, Abdelkhaleq R, Salazar-Marioni S, Zhang GQ, Sheth SA. Predicting In-hospital Mortality Using D-Dimer in COVID-19 Patients With Acute Ischemic Stroke. Frontiers in neurology. 2021;12:702927.
- Rodelo JR, De la Rosa G, Valencia ML, Ospina S, Arango CM, Gómez CI, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. The American journal of emergency medicine. 2012;30(9):1991–9.
- Ganesan R, Mahajan V, Singla K, Konar S, Samra T, Sundaram SK, et al. Mortality Prediction of COVID-19 Patients at Intensive Care Unit Admission. Cureus. 2021;13(11):e19690.
- García-Cervera C, Giner-Galvañ V, Wikman-Jorgensen P, Laureiro J, Rubio-Rivas M, Gurjian Arena A, et al. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry. Journal of general internal medicine. 2021;36(11):3478–86.
- Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis : JTH. 2020;18(5):1094–9.
- Soni M, Gopalakrishnan R, Vaishya R, Prabu P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes & metabolic syndrome. 2020;14(6):2245–9.
- Radonjić T, Milićević O, Jovanović I, Zdravković M, Dukić M, Mandić OM, et al. Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity. Medicina (Kaunas, Lithuania). 2022;58(7).
- Naoum FA, Ruiz ALZ, Martin FHO, Brito THG, Hassem V, Oliveira MGL. Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID-19. International journal of laboratory hematology. 2021;43 Suppl 1(Suppl 1):124–8.
- Gogate N, Lyman D, Bell A, Cauley E, Crandall KA, Joseph A, et al. COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model. Brief Bioinform. 2021;22(6).
- Zhu Y, Sharma L, Chang D. Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review. Frontiers in immunology. 2023;14:1116131.
- Antar AAR, Peluso MJ. CROI 2024: Acute and Post-Acute COVID-19. Top Antivir Med. 2024;32(4):523–41.
Language: English
Page range: 158 - 166
Submitted on: May 4, 2025
Accepted on: Jan 15, 2026
Published on: Apr 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Uyen Thi Bich Nguyen, Hau Phuc Le, Vu Hoang Anh Nguyen, Ai-Thanh Tran-Nguyen, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.